← All products / T

Human research / Tesamorelin

Tesamorelin observational research

A human observational case report on weight change and suspected hypersensitivity during 19 weeks of subcutaneous tesamorelin exposure.

Retrospective · Uncontrolled · n=1

Weight Reduction and Suspected Late-Onset Hypersensitivity Following 19 Weeks of Subcutaneous Tesamorelin

RTP Research · 25 October 2026 · Author-supplied manuscript

The paper documents reported weight and clothing-size changes, concurrent therapies, August and September hormonal laboratory results, and injection-site and systemic cutaneous symptoms. Partial improvement approximately 24 hours after withdrawal does not establish causality or a confirmed allergy. The report does not establish tesamorelin-specific weight-loss efficacy or preservation of lean mass.

Dated photographic documentation

Tesamorelin initiation is reported as June 14, 2026. May 30 and June 1 precede initiation. Six photographs supplied by the participant, presented chronologically from May 30 to August 15, 2026. Participant-supplied visual body-fat estimates: Before (May 30): 18–22%; After (August 15): 10–13%. Illustrative midpoints: 20% → 11.5%; difference: 8.5 percentage points. These approximate visual ranges are unvalidated estimates, not measurements or a verified change in body composition. Lighting, posture, muscle contraction and camera angle can affect apparent definition.

Participant-supplied physique photograph dated May 30, 2026; face blurred
15 days before initiation · Participant-supplied · Face blurred
Participant-supplied physique photograph dated June 1, 2026; face blurred
13 days before initiation · Participant-supplied · Face blurred
Participant-supplied physique photograph dated July 6, 2026; face blurred
22 days after initiation · Participant-supplied · Face blurred
Participant-supplied physique photograph dated July 12, 2026; face blurred
28 days after initiation · Participant-supplied · Face blurred
Participant-supplied physique photograph dated August 1, 2026; face blurred
48 days after initiation · Participant-supplied · Face blurred
Participant-supplied physique photograph dated August 15, 2026; face blurred
62 days after initiation · Participant-supplied · Face blurred

Dates follow the participant’s filenames and confirmation and were not independently authenticated. Only a non-generative facial blur was applied; pixels outside the selected facial regions are unchanged. Other identifying features, including tattoos, remain. These photographs do not establish fat loss, lean-mass gain or a tesamorelin-specific effect, with timing based on the participant-reported June 14, 2026 initiation date.